Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron supplementation optimization after Roux-en-Y gastric bypass
NL-OMON41030Phase 4Recruiting
- Sponsor
- Rijnstate
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ferric carboxymaltose, Ferrous gluconate and ferrous fumarate in iron deficiency anemia (IDA) (4 arms), sponsored by Rijnstate. Primary endpoints: Iron repletion laboratory outcomes, Oral iron absorption profile and 1 more. Started Dec 2014; status: recruiting.
02
Drugs
ferric carboxymaltoseFerrous gluconateferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON41030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41030.